The lead investigator on the South African trial of AstraZeneca’s vaccine said he believed the vaccine had a major role to play in Africa and globally, despite data showing it offered minimal protection against mildtomoderate COVID19 disease by the country’s dominant virus variant.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.